1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Pioglitazone 15 MG [Actos]: new trials by email Literature Review of Pioglitazone 15 MG [Actos] trials Research Report on Pioglitazone 15 MG [Actos]
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes Pioglitazone 15 MG [Actos], Empagliflozin 10 MG [Jardiance], Empagliflozin 10 MG [Jardiance] + Pioglitazone 15 MG [Actos] - Type 2 Diabetes, Fatty Liver | Phase 4 | Recruiting | Seoul National University Bundang Hospital | 120 | 2025-01-01 | 2025-05-25 |
Diabetes Mellitus, Type 2 (1) · Fatty Liver (1)
Seoul National University Bundang Hospital (1)
South Korea (1)